203 related articles for article (PubMed ID: 34040143)
1. Functional characterization of a loss-of-function mutant I324M of arginine vasopressin receptor 2 in X-linked nephrogenic diabetes insipidus.
Wang L; Guo W; Fang C; Feng W; Huang Y; Zhang X; Liu M; Cui J
Sci Rep; 2021 May; 11(1):11057. PubMed ID: 34040143
[TBL] [Abstract][Full Text] [Related]
2. Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus.
Ranadive SA; Ersoy B; Favre H; Cheung CC; Rosenthal SM; Miller WL; Vaisse C
Clin Endocrinol (Oxf); 2009 Sep; 71(3):388-93. PubMed ID: 19170711
[TBL] [Abstract][Full Text] [Related]
3. A novel AVPR2 splice site mutation leads to partial X-linked nephrogenic diabetes insipidus in two brothers.
Schernthaner-Reiter MH; Adams D; Trivellin G; Ramnitz MS; Raygada M; Golas G; Faucz FR; Nilsson O; Nella AA; Dileepan K; Lodish M; Lee P; Tifft C; Markello T; Gahl W; Stratakis CA
Eur J Pediatr; 2016 May; 175(5):727-33. PubMed ID: 26795631
[TBL] [Abstract][Full Text] [Related]
4. Altered agonist sensitivity of a mutant v2 receptor suggests a novel therapeutic strategy for nephrogenic diabetes insipidus.
Erdélyi LS; Balla A; Patócs A; Tóth M; Várnai P; Hunyady L
Mol Endocrinol; 2014 May; 28(5):634-43. PubMed ID: 24628417
[TBL] [Abstract][Full Text] [Related]
5. Characterization of vasopressin V2 receptor mutants in nephrogenic diabetes insipidus in a polarized cell model.
Robben JH; Knoers NV; Deen PM
Am J Physiol Renal Physiol; 2005 Aug; 289(2):F265-72. PubMed ID: 16006591
[TBL] [Abstract][Full Text] [Related]
6. Characterization of three vasopressin receptor 2 variants: an apparent polymorphism (V266A) and two loss-of-function mutations (R181C and M311V).
Armstrong SP; Seeber RM; Ayoub MA; Feldman BJ; Pfleger KD
PLoS One; 2013; 8(6):e65885. PubMed ID: 23762448
[TBL] [Abstract][Full Text] [Related]
7. Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus.
Bockenhauer D; Carpentier E; Rochdi D; van't Hoff W; Breton B; Bernier V; Bouvier M; Bichet DG
Nephron Physiol; 2010; 114(1):p1-10. PubMed ID: 19816050
[TBL] [Abstract][Full Text] [Related]
8. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
Miyakoshi M; Kamoi K; Uchida S; Sasaki S
Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
[TBL] [Abstract][Full Text] [Related]
9. Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments.
Rochdi MD; Vargas GA; Carpentier E; Oligny-Longpré G; Chen S; Kovoor A; Gitelman SE; Rosenthal SM; von Zastrow M; Bouvier M
Mol Pharmacol; 2010 May; 77(5):836-45. PubMed ID: 20159941
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature.
Neocleous V; Skordis N; Shammas C; Efstathiou E; Mastroyiannopoulos NP; Phylactou LA
Metabolism; 2012 Jul; 61(7):922-30. PubMed ID: 22386940
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist.
Makita N; Sato T; Yajima-Shoji Y; Sato J; Manaka K; Eda-Hashimoto M; Ootaki M; Matsumoto N; Nangaku M; Iiri T
J Biol Chem; 2016 Oct; 291(43):22460-22471. PubMed ID: 27601473
[TBL] [Abstract][Full Text] [Related]
12. A low-affinity vasopressin V2-receptor gene in a kindred with X-linked nephrogenic diabetes insipidus.
Yokoyama K; Yamauchi A; Izumi M; Itoh T; Ando A; Imai E; Kamada T; Ueda N
J Am Soc Nephrol; 1996 Mar; 7(3):410-4. PubMed ID: 8704106
[TBL] [Abstract][Full Text] [Related]
13. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
Bichet DG; Bockenhauer D
Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
15. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
16. A novel AVPR2 gene mutation of X-linked congenital nephrogenic diabetes insipidus in an Asian pedigree.
Guo WH; Li Q; Wei HY; Lu HY; Qu HQ; Zhu M
J Int Med Res; 2016 Oct; 44(5):1131-1137. PubMed ID: 27565746
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentials of nonpeptidic V2R agonists for partial cNDI-causing V2R mutants.
Kuramoto R; Kise R; Kanno M; Kawakami K; Ikuta T; Makita N; Inoue A
PLoS One; 2024; 19(5):e0303507. PubMed ID: 38748623
[TBL] [Abstract][Full Text] [Related]
18. An X-linked NDI mutation reveals a requirement for cell surface V2R expression.
Sadeghi HM; Innamorati G; Birnbaumer M
Mol Endocrinol; 1997 Jun; 11(6):706-13. PubMed ID: 9171234
[TBL] [Abstract][Full Text] [Related]
19. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
Wildin RS; Cogdell DE; Valadez V
Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
[TBL] [Abstract][Full Text] [Related]
20. Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation.
Prosperi F; Suzumoto Y; Marzuillo P; Costanzo V; Jelen S; Iervolino A; Guarino S; La Manna A; Miraglia Del Giudice E; Perna AF; Zacchia M; Cordat E; Capasso G; Trepiccione F
Sci Rep; 2020 Oct; 10(1):16383. PubMed ID: 33009446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
